UNSPSC 51422337: Dexamethasone isonicotinate

This classification denotes a therapeutic glucocorticoid with the molecular structure C28H32FNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 8LGC0BOA71 chemically known as pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-((4-pyridinylcarbonyl)oxy)-,(11.beta.,16.alpha.)-, but more commonly known as dexamethasone isonicotinate, which bears US NIH Compound Identifier 16752.

UNSPSC 51422337 Dexamethasone isonicotinate is a Commodity code that does not align with the recent state and local procurement activity tagged to it. The two recent opportunities posted under this code—Seminole County's IFB for Naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescriptions—concern pharmaceutical procurement and pharmacy benefit management infrastructure, not dexamethasone isonicotinate specifically. The code shows little relevant recent activity in the form of direct solicitations for this pharmaceutical product line.

The mismatch between the code's nominal scope and the actual opportunities reflects how state and local procurement systems sometimes tag acquisitions with codes that do not precisely match the goods or services being bought. If pursuing activity in pharmaceutical procurement or pharmacy benefit management at the state and local level, review the actual opportunities directly rather than relying on this code's tag. The Seminole County and Texas HHS opportunities signal demand for naloxone procurement and pharmacy program redesign, but they do not represent a sustained or clearly categorized market under UNSPSC 51422337.